Pharmaceutical - USA, Markets & Marketing

Filter

Current filters:

USAMarkets & Marketing

Popular Filters

1 to 25 of 55 results

Rheumatoid arthritis drug market will grow to $18.2 billion in 2023, report

17-09-2014

The rheumatoid arthritis (RA) disease-modifying antirheumatic drug market will increase from $14 billion…

Anti-Arthritics/RheumaticsbaricitinibBiosimilarsEli LillyEuropeIncyteJapanMarkets & MarketingPfizerPharmaceuticalUSAVertexXeljanz

Lundbeck launches Northera in USA

Lundbeck launches Northera in USA

02-09-2014

Danish CNS specialist Lundbeck said today that Northera (droxidopa) capsules for oral use are now available…

Chelsea TherapeuticsLundbeckMarkets & MarketingNeurologicalNortheraPharmaceuticalUSA

Colorectal cancer market will remain steady at $7.7 billion by 2023; report

29-08-2014

The market for colorectal cancer (CRC) therapies will remain constant, at around $7.7 billion by 2023…

EuropeJapanMarkets & MarketingOncologyPharmaceuticalUSA

Globavir to seek approval and launch of novel Ebola treatment by year-end

Globavir to seek approval and launch of novel Ebola treatment by year-end

19-08-2014

Privately-held US biotech firm Globavir Biosciences said yesterday that it intends to develop its lead…

Antibiotics and Infectious diseasesGBV006Globavir BiosciencesMarkets & MarketingPharmaceuticalRegulationRest of the WorldTropical diseasesUSA

Belsomra could become first-line insomnia therapy, says GlobalData

Belsomra could become first-line insomnia therapy, says GlobalData

18-08-2014

Insomnia treatment Belsomra (suvorexant) from US pharma giant Merck & Co has the potential to become…

BelsomraChemistryCyclopyrrolonesInsomniaMarkets & MarketingMerck & CoNeurologicalOrganic chemistryPharmaceuticalUSA

Turkish man pleads guilty to importing illegal cancer drugs into USA

Turkish man pleads guilty to importing illegal cancer drugs into USA

17-08-2014

Sabahaddin Akman, owner of the Istanbul, Turkey, firm Ozay Pharmaceuticals, has pleaded guilty to charges…

AvastinLegalMarkets & MarketingOncologyOzay PharmaceuticalsPharmaceuticalRituxanSabahaddin AkmanTurkeyUSA

MS market to reach $20 billion in 2023 boosted by five new therapies

MS market to reach $20 billion in 2023 boosted by five new therapies

08-08-2014

The forecast launch of five immunomodulatory therapies for relapsing forms of multiple sclerosis will…

CNS DiseasesEuropeImmunosuppressantsJapanMarkets & MarketingMSPharmaceuticalUSA

Nicox and Bausch + Lomb to co-promote latanoprostene bunod for glaucoma

Nicox and Bausch + Lomb to co-promote latanoprostene bunod for glaucoma

08-08-2014

International opthalmic company Nicox is to co-promote latanoprostene bunod with Bausch + Lomb, the eyecare…

Bausch & LombCanadaGlaucomaLatanoprost OphthalmicMarkets & MarketingNicOxOphthalmicsOpticsPharmaceuticalUSA

Aeterna Zentaris and Ascend Therapeutics team up to market each other's products

Aeterna Zentaris and Ascend Therapeutics team up to market each other's products

05-08-2014

Quebec-based biopharma drug developer Aeterna Zentaris has said it is to collaborate with women’s healthcare…

AEterna ZentarisAscend PharmaClinical researchDavid DoddEstroGelHealthcare specialistMarkets & MarketingPharmaceuticalPharmaceutical sciencesUSAWomen's Health

US and European orphan status for AbbVie’s glioblastoma candidate

US and European orphan status for AbbVie’s glioblastoma candidate

04-08-2014

Both the European Medicines Agency and the US Food and Drug Administration have granted orphan drug designation…

AbbVieABT-414Brain tumorEuropeGlioblastoma multiformeMarkets & MarketingOncologyPharmaceuticalRare diseasesRegulationUS Food and Drug AdministrationUSA

Acute coronary syndrome treatment market to more than triple by 2023

Acute coronary syndrome treatment market to more than triple by 2023

30-07-2014

The launch of several drugs with “extraordinary blockbuster potential” will cause the acute coronary…

Acute coronary syndromealirocumabAmgenBayerCardio-vascularEuropeevolocumabJapanMarkets & MarketingMerck & CoPfizerPharmaceuticalSanofiUSAXareltoZontivity

FedEx Corp indicted for illegally distributing prescription drugs in USA

FedEx Corp indicted for illegally distributing prescription drugs in USA

18-07-2014

The US Attorney for the Northern District of California yesterday charged the FedEx Corporation with…

LegalMarkets & MarketingPharmaceuticalPharmaceutical sciencesUS AttorneyUSA

Drug-treated hepatitis C population to more than double by 2016

Drug-treated hepatitis C population to more than double by 2016

16-07-2014

The hepatitis C virus population is already large, with 2 million diagnosed, chronically infected cases…

Anti-viralsCytokinesDaklinzaDecision Resources GroupEuropeHepatitis CInterferonJapanMarkets & MarketingPharmaceuticalUSA

Lundbeck and Otsuka file for US approval of brexpiprazole

Lundbeck and Otsuka file for US approval of brexpiprazole

14-07-2014

Danish CNS drug specialist Lundbeck and Japanese drugmaker Otsuka have submitted a New Drug Application…

brexpiprazoleLundbeckMarkets & MarketingNeurologicalOtsukaPharmaceuticalPiperidinesRegulationUSA

US nephrologists view hyperphosphatemia treatment

US nephrologists view hyperphosphatemia treatment

11-07-2014

Surveyed nephrologists report awareness of the US Food and Drug Administration's approval of Vifor Fresenius…

AmgenFreseniusGlaxoSmithKlineLa Jolla PharmaceuticalMarkets & MarketingNephrology and HepatologyOPKO HealthPharmaceuticalRayaldeeSensiparUSAvelcalcetideVelphoroVenoferVifor Pharma

Fidia completes establishment of operations in North America

Fidia completes establishment of operations in North America

08-07-2014

Fidia Pharma USA, a wholly-owned subsidiary of privately-held Italian drugmaker Fidia Farmaceutici, says…

Anti-Arthritics/RheumaticsFidia FarmaceuticiManagementMarkets & MarketingPharmaceuticalUSA

Glowing prospects for Novo Nordisk's insulin degludec/liraglutide for type 2 diabetes

Glowing prospects for Novo Nordisk's insulin degludec/liraglutide for type 2 diabetes

07-07-2014

Danish diabetes care giant Novo Nordisk's fixed-dose combination therapy insulin degludec/liraglutide…

DiabetesEuropeIDegLiraMarkets & MarketingNovo NordiskPharmaceuticalUSAXultophy

New entrants in chronic lymphocytic leukemia will raise market value to $3.3 billion by 2018

New entrants in chronic lymphocytic leukemia will raise market value to $3.3 billion by 2018

02-07-2014

The introduction of several new drugs will accelerate growth in the chronic lymphocytic leukemia treatment…

EuropeidelalisibImbruvicaMarkets & MarketingOncologyPharmaceuticalUSA

US psychiatrists’ views on prescribing Otsuka/Lundbeck’s brexpiprazole

26-06-2014

Surveyed US psychiatrists are receptive to novel adjunctive therapies to antidepressants for treatment-resistant…

brexpiprazoleBrintellixLundbeckMarkets & MarketingNeurologicalOtsukaPharmaceuticalUSA

Rilutek patent expiry to cause negative growth in ALS treatment market by 2018

Rilutek patent expiry to cause negative growth in ALS treatment market by 2018

25-06-2014

The amyotrophic lateral sclerosis (ALS) treatment market value will decline from $64 million in 2013…

EuropeJapanMarkets & MarketingNeurologicalPatentsPharmaceuticalRilutekSanofiUSA

Novo Nordisk launch new insulin device Levemir FlexTouch in USA

Novo Nordisk launch new insulin device Levemir FlexTouch in USA

19-06-2014

Danish diabetes care giant Novo Nordisk has launched its newest prefilled insulin delivery device Levemir…

DiabetesLevemirMarkets & MarketingNovo NordiskPharmaceuticalUSA

US FDA issues guidance on new risk information dissemination

US FDA issues guidance on new risk information dissemination

09-06-2014

Late last Friday afternoon, the US Food and Drug Administration issued a new guidance document describing…

Markets & MarketingPharmaceuticalRegulationUSA

Top 5% of opioid prescribers write 40% of US narcotic prescriptions

Top 5% of opioid prescribers write 40% of US narcotic prescriptions

09-06-2014

In the USA, 40% of narcotic prescriptions in 2011-2012 were written by only 5% of opioid prescribers,…

Markets & MarketingNeurologicalPharmaceuticalUSA

1 to 25 of 55 results

Back to top